UK Biobank
Illumina Launches Pilot Proteomics Study With UK Biobank, Inks Partnership With Nvidia
In collaboration with UK Biobank and pharma partners, Illumina will analyze 50,000 samples using the upcoming Protein Prep assay and NovaSeq X Plus platform.
A total of 600,000 samples will be analyzed by the Regeneron Genetics Center using the Olink Explore HT proteomics assay and the Ultima Genomics sequencing platform.
Data from Myriad Genetics offered early validation evidence for an expanded version of its commercial test, as well as a look into clinical impact via claims data.
Researchers uncovered 13 blood plasma-based protein markers for brain aging while highlighting three inflection points in the late 50s, early 70s, and late 70s.
Biobanks have been making strides in gathering data from more diverse populations this year while the evidence for the clinical utility of embryo PRS testing remains insufficient.